ABOUT US
Shenzhen Jiantong Pharm Technology Co., Ltd. was founded in 2003, a company of Zhushi Pharm Group which has over 5,000 full-time employees and annual output value of 5 billion RMB. It has built research and development, production, and marketing bases in Jinan, Shanghai, Guangdong, Tianjin, Shaanxi, Guizhou, Gansu, Hunan, Hubei, Anhui, Jiangsu, and other places. The group has invested in the construction of two modern and technological health industry parks, covering a total area of over 500 acres.
Group phaseI project: Built in 2003
Production No.1 Company of Shenzhen Jiantong Pharmaceutical Group, founded in December 2003, located atNo.6,Dande Road,Economic Development Zone,ShanxianCounty, covering an area of 68 mu,is the birthplace of ZhuPharmaceutical Group, currently mainly produces pastes.patches, gels,polymers, protective suit and other products.and has more than 800 production and sales workers.
Group phase Il project: Built in 2015
No. 2 Company mainly comprises Danwick testing centerhealth food, cosmetics workshop, large conference center(which can accommodate 1500 people), and sales building;the first and sixth floors of the sales building provide businessdining and hotel services for customers; Floor 2/3/4/5 is oursales and marketing center, with more than 1,500 employees.
Group phase Ill project: Built in 2018
The first floor of the administrative center of No. 3Company is our high-end medical device modernizationexhibition hall, and the second floor is our sanitary disinfectionproduct production workshop.Workshop 2 is the modernprinting workshop; Workshop 3 is our high-end medical deviceproduction workshop; Workshop 5 is the large testing centerof the Group; Workshop 6 is the in vitro diagnostic reagentproduction workshop.
Group phase IVproject: Built in 2020
No. 4 Company is of great significance to the Group. As amajor construction project in Shandong Province, we plan tobuild an active equipment workshop of 10,000 square metersincluding CT,nuclear magnetic resonance and X-ray imagingsystem. In the first stage, it is estimated that 2.4 million syringes700,000 infusion syringes and 50, 000 indwelling needles will beproduced per day.
